CYTK · Categories · Coverage
CYTK - Analyst coverage initiated
Cytokinetics Incorporated (CYTK) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for CYTK
- Citigroup initiated coverage on Cytokinetics with a new price targetCitigroup initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $99.00
- Wells Fargo initiated coverage on Cytokinetics with a new price targetWells Fargo initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $95.00
- Barclays initiated coverage on Cytokinetics with a new price targetBarclays initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $55.00
- Citigroup initiated coverage on Cytokinetics with a new price targetCitigroup initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $86.00
- Stifel initiated coverage on Cytokinetics with a new price targetStifel initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $80.00
- RBC Capital Mkts initiated coverage on Cytokinetics with a new price targetRBC Capital Mkts initiated coverage of Cytokinetics with a rating of Outperform and set a new price target of $80.00
- Goldman initiated coverage on Cytokinetics with a new price targetGoldman initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $50.00
- B. Riley Securities initiated coverage on Cytokinetics with a new price targetB. Riley Securities initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $66.00
- SVB Securities initiated coverage on Cytokinetics with a new price targetSVB Securities initiated coverage of Cytokinetics with a rating of Outperform and set a new price target of $58.00
- BofA Securities initiated coverage on Cytokinetics with a new price targetBofA Securities initiated coverage of Cytokinetics with a rating of Neutral and set a new price target of $49.00
- Truist initiated coverage on Cytokinetics with a new price targetTruist initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $60.00
- UBS initiated coverage on Cytokinetics with a new price targetUBS initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $80.00
- Goldman initiated coverage on Cytokinetics with a new price targetGoldman initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $74.00
- Oppenheimer initiated coverage on Cytokinetics with a new price targetOppenheimer initiated coverage of Cytokinetics with a rating of Outperform and set a new price target of $55.00
- JP Morgan initiated coverage on Cytokinetics with a new price targetJP Morgan initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $58.00
- Jefferies initiated coverage on Cytokinetics with a new price targetJefferies initiated coverage of Cytokinetics with a rating of Buy and set a new price target of $75.00
- Wolfe Research initiated coverage on Cytokinetics with a new price targetWolfe Research initiated coverage of Cytokinetics with a rating of Outperform and set a new price target of $50.00
- Wolfe Research initiated coverage on CytokineticsWolfe Research initiated coverage of Cytokinetics with a rating of Outperform
- Barclays initiated coverage on Cytokinetics with a new price targetBarclays initiated coverage of Cytokinetics with a rating of Overweight and set a new price target of $28.00
- Barclays initiated coverage on CytokineticsBarclays initiated coverage of Cytokinetics with a rating of Overweight